197 related articles for article (PubMed ID: 30935584)
1. Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series.
Leonardi MC; Corrao G; Frassoni S; Vingiani A; Dicuonzo S; Lazzeroni M; Fodor C; Morra A; Gerardi MA; Rojas DP; Dell'Acqua V; Marvaso G; Bassi FD; Galimberti VE; Veronesi P; Miglietta E; Cattani F; Zurrida S; Bagnardi V; Viale G; Orecchia R; Jereczek-Fossa BA
Radiother Oncol; 2019 Apr; 133():68-76. PubMed ID: 30935584
[TBL] [Abstract][Full Text] [Related]
2. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M
Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123
[TBL] [Abstract][Full Text] [Related]
3. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
4. Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups.
Zauls AJ; Watkins JM; Wahlquist AE; Brackett NC; Aguero EG; Baker MK; Jenrette JM; Garrett-Mayer E; Harper JL
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):21-9. PubMed ID: 20951508
[TBL] [Abstract][Full Text] [Related]
5. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology.
Leonardi MC; Maisonneuve P; Mastropasqua MG; Morra A; Lazzari R; Rotmensz N; Sangalli C; Luini A; Veronesi U; Orecchia R
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):806-13. PubMed ID: 22245196
[TBL] [Abstract][Full Text] [Related]
6. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast.
Fisher ER
CA Cancer J Clin; 1997; 47(1):52-64. PubMed ID: 8996078
[TBL] [Abstract][Full Text] [Related]
7. A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology.
Stull TS; Catherine Goodwin M; Gracely EJ; Chernick MR; Carella RJ; Frazier TG; Barrio AV
Ann Surg Oncol; 2012 Feb; 19(2):553-9. PubMed ID: 21769461
[TBL] [Abstract][Full Text] [Related]
8. Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons: An Insight into Management and Outcome from an Italian Multicentric Study.
Leonardi MC; Tomio L; Radice D; Takanen S; Bonzano E; Alessandro M; Ciabattoni A; Ivaldi GB; Bagnardi V; Alessandro O; Francia CM; Fodor C; Miglietta E; Veronesi P; Galimberti VE; Orecchia R; Tagliaferri L; Vidali C; Massaccesi M; Guenzi M; Jereczek-Fossa BA;
Ann Surg Oncol; 2020 Mar; 27(3):752-762. PubMed ID: 31732946
[TBL] [Abstract][Full Text] [Related]
9. External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial.
Becherini C; Meattini I; Livi L; Garlatti P; Desideri I; Scotti V; Orzalesi L; Sanchez LJ; Bernini M; Casella D; Nesi S; Nori J; Bianchi S; Pallotta S; Marrazzo L
Tumori; 2019 Jun; 105(3):205-209. PubMed ID: 30474504
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features.
McHaffie DR; Patel RR; Adkison JB; Das RK; Geye HM; Cannon GM
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):46-51. PubMed ID: 20732760
[TBL] [Abstract][Full Text] [Related]
11. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
[TBL] [Abstract][Full Text] [Related]
12. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
13. Management of ductal carcinoma in situ with accelerated partial breast irradiation brachytherapy: Implications for guideline expansion.
Mills MN; Russo NW; Nanda RH; Wilson JP; Altoos TA; Caldwell DL; Stout LL; Dube S; Blumencranz PW; Allen KG; Diaz R
Brachytherapy; 2021; 20(2):345-352. PubMed ID: 33317964
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
15. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.
Trombetta M; Hall M; Julian TB
Brachytherapy; 2014; 13(5):488-92. PubMed ID: 24950822
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial testing a hyaluronic acid spacer injection for skin toxicity reduction of brachytherapy accelerated partial breast irradiation (APBI): a study protocol.
Struik GM; Godart J; Verduijn GM; Kolkman-Deurloo IK; de Vries KC; de Boer R; Koppert LB; Birnie E; Ghandi A; Klem TM; Pignol JP
Trials; 2018 Dec; 19(1):689. PubMed ID: 30558672
[TBL] [Abstract][Full Text] [Related]
17. Trends in the use of implantable accelerated partial breast irradiation for ductal carcinoma in situ: Implications of the recent amendments to the American Society for Radiation Oncology consensus guidelines.
Haque W; Verma V; Haque A; Butler EB; Teh BS
Brachytherapy; 2017; 16(2):402-408. PubMed ID: 28063816
[TBL] [Abstract][Full Text] [Related]
18. Accelerated partial breast irradiation for pure ductal carcinoma in situ.
Park SS; Grills IS; Chen PY; Kestin LL; Ghilezan MI; Wallace M; Martinez AM; Vicini FA
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):403-8. PubMed ID: 20800374
[TBL] [Abstract][Full Text] [Related]
19. Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation.
Smith GL; Jiang J; Buchholz TA; Xu Y; Hoffman KE; Giordano SH; Hunt KK; Smith BD
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):274-84. PubMed ID: 24268788
[TBL] [Abstract][Full Text] [Related]
20. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.
Strnad V; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Gutierrez Miguelez C; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Wendt TG; Fietkau R; Hindemith M; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Malzer M; Uter W; Polgár C;
Lancet; 2016 Jan; 387(10015):229-38. PubMed ID: 26494415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
